UTMB Health Graduate School of Biomedical Sciences Admission Process
Graduate education at UTMB Health is organized and administered
within the Graduate School of Biomedical Sciences (GSBS), a
well-established component of UTMB Health. The GSBS was founded as a
free-standing graduate school in 1969 and has 15 programs, 13 of which
award doctoral degrees.
These programs cross departmental boundaries and facilitate
interdisciplinary research and teaching. All GSBS faculty have primary
academic appointments either in the School of Medicine, Nursing, or
Allied Health Professions and are often members of campus-based research
centers or institutes such as the Institute for Human Infections and
The GSBS admissions process
is open between December and April for Fall term (Aug-Sept) entry. Applications are submitted through a centralized GSBS web based application
and then forwarded to a specific program admission committee based
upon the applicant’s stated interest and experience. The Experimental
Pathology Admissions and Recruitment Committee is responsible
for selecting qualified applicants for our Program. Applicants are
evaluated based on many factors including, but not limited to,
undergraduate academic performance, GRE test scores, research
experience, personal statements, letters of recommendation, and
Graduate Student Support
Student stipends and tuition rates are determined by UTMB Health GSBS.
First year students are supported by the GSBS, but subsequent support
is provided by the student’s mentor upon entering a specific program.
In 2017, 75% of our students were supported by extramural grants
awarded to their mentors and 25% were supported by NIH supported
training grants or by funds provided through intramural mechanisms.
Current predoctoral NIH supported training opportunities are available
through the T32 Vector-borne Diseases Training Program (PI- Dr. Lynn Soong) and the T32 Biodefense Training Program (PI-Dr. Scott Weaver). Students are also supported by other sources including the McLaughlin Endowment and the Sealy Institute for Vaccine Sciences.